Pinned straw:
Yeah very disappointing
I can't seem to win a trick lately. Thankfully I didn't buy as much in real live as in my Strawman portfolio. But still enough to hurt
It will be interesting to see the results of the second phase 3 trial, which uses the same drug combo as the fairly large and highly positive phase 2 trial
But it is hard to see this being worth anything other than zero
Pretty grim summary..Opthea Announces COAST Phase 3 Trial Topline Results
COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from
baseline to week 52
Opthea considering impact of negative trial results under its Development Funding Agreement and on the Company as a going concern